About Ranibizumab
            
            Class: | Monoclonal antibody (VEGF inhibitor)  
Use: | Treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV)  
Adult dose: | 0.5 mg (0.05 mL) injected intravitreally once a month; may be adjusted based on clinical response  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended  
Side effects: | Common side effects include conju
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (VEGF inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: MS PHARMA SAUDI[Riyadh;Saudi Arabia], Saudi Arabia
                    
                    
                    Package Size
                    1 Glass Vial (0.23 mL)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2803.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        0.5 mg (0.05 mL) injected intravitreally once a month; may be adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include conjunctival hemorrhage, eye pain, increased intraocular pressure, and retinal detachment
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to ranibizumab or any component of the formulation; active ocular or periocular infections; recent ocular surgery
         
        
        
            
                Important Warnings
            
            Risk of endophthalmitis; monitor for signs of intraocular inflammation; potential for arterial thromboembolic events; caution in patients with a history of thromboembolic events
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.